Close Menu

NEW YORK — Women's health diagnostic firm Progenity on Thursday announced a 70 percent drop in second quarter revenues, its first financial results since going public earlier this year.

For the three-month period ended June 30, Progenity reported $17.3 million in revenue, down from $57.2 million in the year-ago quarter. Second quarter revenues were impacted by "a $10.3 million accrual for refunds to government payors," the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.